Literature DB >> 15940289

Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.

N Gambier1, A-M Batt, B Marie, M Pfister, G Siest, S Visvikis-Siest.   

Abstract

This study was designed in order to investigate the influence of the genetic polymorphism of CYP2A6 on the amount of smoking. In all, 463 French adults included in the Stanislas cohort were studied and underwent two examinations at 5 years distance (t0 and t(+5) years). Information on their smoking habits was collected. They were genotyped by RFLP for the CYP2A6*1A, CYP2A6*1B and CYP2A6*4 alleles. CYP2A6*1B and CYP2A6*4 allele frequencies were 32 and 4%, respectively. The subjects carrying the CYP2A6*1B allele oxidize nicotine to cotinine faster than subjects with the CYP2A6*1A allele. The number of cigarettes smoked per day was significantly higher in the CYP2A6*1B/*1B group as compared to the CYP2A6*1A/*1A group (P = 0.01 at t0; P = 0.001 t(+5) years), with a larger increase in their daily cigarettes consumption over the 5-year period (P = 0.006). No significant difference in the smoking status was observed according to the CYP2A6 genotype. These data suggest that the CYP2A6*1B is associated with the number of cigarettes smoked per day.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940289     DOI: 10.1038/sj.tpj.6500314

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  11 in total

Review 1.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Authors:  Cheyenne E Allenby; Kelly A Boylan; Caryn Lerman; Mary Falcone
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-12       Impact factor: 4.147

2.  CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.

Authors:  Yu-liang Liu; Yu Xu; Fan Li; Hong Chen; Shu-liang Guo
Journal:  Tumour Biol       Date:  2013-05-07

Review 3.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

4.  In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Authors:  Natasa Djordjevic; Juan Antonio Carrillo; Guillermo Gervasini; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

5.  Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.

Authors:  Ju Wang; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

6.  Smoking topography in Korean American and white men: preliminary findings.

Authors:  Sangkeun Chung; Sun S Kim; Nisha Kini; Hua J Fang; David Kalman; Douglas M Ziedonis
Journal:  J Immigr Minor Health       Date:  2015-06

7.  Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.

Authors:  Quinn S Wells; Matthew S Freiberg; Robert A Greevy; Rachel F Tyndale; Suman Kundu; Meredith S Duncan; Stephen King; Lesa Abney; Elizabeth Scoville; Dawn B Beaulieu; Vanessa Gatskie; Hilary A Tindle
Journal:  Nicotine Tob Res       Date:  2018-11-15       Impact factor: 4.244

8.  Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.

Authors:  J C Mwenifumbo; C N Lessov-Schlaggar; Q Zhou; R E Krasnow; G E Swan; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2007-05-23       Impact factor: 6.875

Review 9.  Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.

Authors:  Luis A López-Flores; Gloria Pérez-Rubio; Ramcés Falfán-Valencia
Journal:  EXCLI J       Date:  2017-03-06       Impact factor: 4.068

10.  Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis.

Authors:  Lishan Wang
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.